Regulatory Updates

FDA Draft Guidance Slashes Biosimilar PK Study Costs, Accelerating Market Entry

FDA · 6 min

FDA Expands ENDS Market Access: Implications for Pharma BD and Investors

FDA · 8 min

Lilly and Gilead Drive Pharma M&A Surge: A Strategic Market Analysis

FDA · cancer · 7 min

Amgen and Zai Lab Leadership Shifts: Strategic Implications for Pharma BD and Investors

FDA · neurology · 8 min

FDA's New Stance on Drug Pricing: Impact on Approvals and Pharma Strategy

FDA · 7 min

Roche's Alecensa Secures Expanded Approval in Japan for ALK-Positive Lung Cancer

FDA · ALK Tumors · 9 min

Biogen Faces Italian Antitrust Probe: What It Means for the Multiple Sclerosis Market

FDA · multiple sclerosis · 10 min

Candel's Prostate Cancer Drug: Long-Term Data Insights Ahead of FDA Filing

FDA · prostate cancer · 8 min

Citius Pharmaceuticals Stock Update: Cancer and Anti-Infective Pipeline Insights

FDA · cancer · 11 min

FDA to Issue Guidance on Animal-Derived Thyroid Products by August 2026, Signaling Regulatory Shift

FDA · Graves' Disease · 8 min

Global Regulatory Roundup: Key Updates for June 1, 2026

FDA · Dermatologicals · 7 min

Biotech M&A Trends: Navigating the 2026 Outlook for Strategic Growth

9 min